HIV-1 entry inhibitors: Evading the issue

被引:0
|
作者
Nelson L. Michael
John P. Moore
机构
[1] Walter Reed Army Institute of Research,
[2] The Aaron Diamond AIDS Research Center,undefined
[3] The Rockefeller University,undefined
来源
Nature Medicine | 1999年 / 5卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
HIV-1 entry into cells is an attractive target for new antiviral agents. But will inhibitors aimed at the CCR5 co-receptor force HIV-1 to evolve more virulent forms?
引用
收藏
页码:740 / 742
页数:2
相关论文
共 50 条
  • [21] Resistance against inhibitors of HIV-1 entry into target cells
    Kramer, Victor G.
    Wainberg, Mark A.
    FUTURE VIROLOGY, 2015, 10 (02) : 97 - 112
  • [22] Co-receptor antagonists as HIV-1 entry inhibitors
    Shaheen, F
    Collman, RG
    CURRENT OPINION IN INFECTIOUS DISEASES, 2004, 17 (01) : 7 - 16
  • [23] Potent D-peptide inhibitors of HIV-1 entry
    Welch, Brett D.
    VanDemark, Andrew P.
    Heroux, Annie
    Hill, Christopher P.
    Kay, Michael S.
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (43) : 16828 - 16833
  • [24] Structure Optimization of Aloperine Derivatives as HIV-1 Entry Inhibitors
    Dang, Zhao
    Xie, Hua
    Zhu, Lei
    Zhang, Qjngye
    Li, Zhijun
    Huang, Li
    Chen, Chin-Ho
    ACS MEDICINAL CHEMISTRY LETTERS, 2017, 8 (11): : 1199 - 1203
  • [25] Updating the Use of Synthetic Peptides as Inhibitors of HIV-1 Entry
    Jose Gomara, Maria
    Haro, Isabel
    CURRENT MEDICINAL CHEMISTRY, 2014, 21 (10) : 1188 - 1200
  • [26] HIV-1 entry inhibitors: new targets, novel therapies
    Pierson, TC
    Doms, RW
    IMMUNOLOGY LETTERS, 2003, 85 (02) : 113 - 118
  • [27] HIV-1 entry inhibitors: recent development and clinical use
    Henrich, Timothy J.
    Kuritzkes, Daniel R.
    CURRENT OPINION IN VIROLOGY, 2013, 3 (01) : 51 - 57
  • [28] Coevolution and subsite decomposition for the design of resistance-evading HIV-1 protease inhibitors
    Rosin, CD
    Belew, RK
    Walker, WL
    Morris, GM
    Olson, AJ
    Goodsell, DS
    JOURNAL OF MOLECULAR BIOLOGY, 1999, 287 (01) : 77 - 92
  • [29] Current Status of the Pharmacokinetics and Pharmacodynamics of HIV-1 Entry Inhibitors and HIV Therapy
    Xu, Fengyan
    Acosta, Edward P.
    Liang, Liyu
    He, Yingchun
    Yang, Juan
    Kerstner-Wood, Corenna
    Zheng, Qingshang
    Huang, Jihan
    Wang, Kun
    CURRENT DRUG METABOLISM, 2017, 18 (08) : 769 - 781
  • [30] Rational design of novel HIV-1 entry inhibitors by RANTES engineering
    Vangelista, Luca
    Secchi, Massimiliano
    Lusso, Paolo
    VACCINE, 2008, 26 (24) : 3008 - 3015